Dec 9
Current report
8-K
Events of Dec 7
Director or officer change, or executive pay
BMRA · Biomerica Inc · Documents
$1.30
-0.21 (-13.91%)
At close · Nov 12
Return incl. dividend (before tax)
Going-concern doubt
— flagged Oct 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about our ability to continue as a going concern within twelve months following the issuance date of these financial statements. Our future viability depends on the successful execution of our strategic plans, securing additional near-term financing, and achieving profitable operations.”View the 10-Q filed Oct 15, 2026
Market Cap
$5.98M
Shares
4.60M
Volume · Nov 12
30.44K
Avg daily vol (3M)
71.8K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →
2022
Dec 9
Current report
8-K
Events of Dec 7
Shareholder vote results
Nov 14
Current report
8-K
Regulation FD disclosure
Oct 13
Quarterly report
10-Q
FY2023 Q1, ended Aug 31
Quarterly report for FY2023 Q1
Revenue $1.64M
▲ 29.8%
Net loss $2.07M
Diluted EPS -$0.16
Sep 27
Proxy statement
DEF 14A
Meeting Dec 7, 2022
Proxy statement
Aug 29
Annual report
10-K
FY2022, ended May 31
Annual report for FY2022
Revenue $18.87M
▲ 162.1%
Net loss $4.53M
Diluted EPS -$0.36
Apr 19
Current report
8-K
Change of auditor
Apr 14
Quarterly report
10-Q
FY2022 Q3, ended Feb 28
Quarterly report for FY2022 Q3
Revenue $7.66M
▲ 111.1%
Net loss $104.17K
Diluted EPS -$0.01
Feb 10
Current report
8-K
Events of Feb 8
Regulation FD disclosure, Other events
Jan 12
Quarterly report
10-Q
FY2022 Q2, ended Nov 30
Quarterly report for FY2022 Q2
Revenue $4.65M
▲ 238.6%
Net loss $1.13M
Diluted EPS -$0.09
2021
Dec 16
Current report
8-K
Financial results, Other events
Dec 10
Current report
8-K
Events of Dec 9
Shareholder vote results
Dec 7
Current report
8-K
Events of Dec 2
Other events
Oct 14
Annual report
10-K/A
FY2021, ended May 31
Annual report for FY2021
Revenue $7.2M
▲ 7.6%
Net loss $7.45M
Diluted EPS -$0.62
Oct 14
Quarterly report
10-Q
FY2022 Q1, ended Aug 31
Quarterly report for FY2022 Q1
Revenue $1.26M
▲ 10.3%
Net loss $1.54M
Diluted EPS -$0.12
Sep 30
Current report
8-K
Earlier financial statements no longer reliable
Sep 28
Proxy statement
DEF 14A
Meeting Dec 9, 2021
Proxy statement
Aug 27
Annual report
10-K
FY2021, ended May 31
Annual report for FY2021
Revenue $7.2M
▲ 7.6%
Net loss $6.47M
Diluted EPS -$0.54
Jun 25
Current report
8-K
Events of Jun 24
Regulation FD disclosure, Other events
Apr 14
Quarterly report
10-Q
FY2021 Q3, ended Feb 28
Quarterly report for FY2021 Q3
Revenue $3.63M
▲ 208.3%
Net loss $1.84M
Diluted EPS -$0.15
Jan 22
Current report
8-K
Other events
Jan 14
Current report
8-K
Events of Jan 12
Regulation FD disclosure, Other events
Jan 14
Quarterly report
10-Q
FY2021 Q2, ended Nov 30
Quarterly report for FY2021 Q2
Revenue $1.37M
▼ 14.0%
Net loss $1.49M
Diluted EPS -$0.13
2020
Dec 11
Current report
8-K
Director or officer change, or executive pay
Dec 11
Current report
8-K
Shareholder vote results
Oct 15
Quarterly report
10-Q
FY2021 Q1, ended Aug 31
Quarterly report for FY2021 Q1
Revenue $1.14M
▼ 4.2%
Net loss $1.65M
Diluted EPS -$0.14
Sep 25
Proxy statement
DEF 14A
Meeting Dec 10, 2020
Proxy statement
Sep 11
Registration statement
S-3/A
Registration statement
Sep 2
Current report
8-K
Events of Sep 1
Regulation FD disclosure
Sep 2
Current report
8-K
Events of Aug 27
Director or officer change, or executive pay, Regulation FD disclosure, Other events
Aug 31
Annual report
10-K
FY2020, ended May 31
Annual report for FY2020
Revenue $6.69M
▲ 28.7%
Net loss $2.34M
Diluted EPS -$0.23
Jul 21
Registration statement
S-3
Registration statement
Jun 29
Current report
8-K
Regulation FD disclosure, Other events
Jun 17
Current report
8-K
Events of Jun 16
Regulation FD disclosure, Other events
Jun 2
Current report
8-K
Events of Jun 1
Regulation FD disclosure, Other events
May 11
Current report
8-K
Events of May 7
Regulation FD disclosure, Other events
Apr 14
Quarterly report
10-Q
FY2020 Q3, ended Feb 29
Quarterly report for FY2020 Q3
Revenue $1.18M
▼ 6.7%
Net loss $860.93K
Diluted EPS -$0.09
Apr 6
Current report
8-K
Events of Apr 1
Entered into a material agreement, Regulation FD disclosure
Mar 20
Current report
8-K
Other events
Mar 18
Current report
8-K
Events of Mar 17
Other events
Feb 27
Jan 14
Quarterly report
10-Q
FY2020 Q2, ended Nov 30
Quarterly report for FY2020 Q2
Revenue $1.6M
▲ 6.4%
Net loss $485.26K
Diluted EPS -$0.05
Jan 9
Current report
8-K
Regulation FD disclosure
Showing 51–93 of 93 documents